GR3003819T3 - - Google Patents

Info

Publication number
GR3003819T3
GR3003819T3 GR920400241T GR920400241T GR3003819T3 GR 3003819 T3 GR3003819 T3 GR 3003819T3 GR 920400241 T GR920400241 T GR 920400241T GR 920400241 T GR920400241 T GR 920400241T GR 3003819 T3 GR3003819 T3 GR 3003819T3
Authority
GR
Greece
Prior art keywords
apolipoproteins
fractions
lipoproteins
suspending
suspensions
Prior art date
Application number
GR920400241T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003819T3 publication Critical patent/GR3003819T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GR920400241T 1988-02-08 1992-02-18 GR3003819T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH43188 1988-02-08

Publications (1)

Publication Number Publication Date
GR3003819T3 true GR3003819T3 (enExample) 1993-03-16

Family

ID=4186866

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400241T GR3003819T3 (enExample) 1988-02-08 1992-02-18

Country Status (8)

Country Link
US (1) US5089602A (enExample)
EP (1) EP0329605B1 (enExample)
JP (1) JP2756132B2 (enExample)
AT (1) ATE72121T1 (enExample)
CA (1) CA1335077C (enExample)
DE (1) DE58900776D1 (enExample)
ES (1) ES2042058T3 (enExample)
GR (1) GR3003819T3 (enExample)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2083152T3 (es) * 1990-11-30 1996-04-01 Monoclonetics Int Metodos para el diagnostico de dolores cronicos lumbares y cervicales.
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas
EP0604823A1 (en) * 1992-12-29 1994-07-06 International Business Machines Corporation Triazine polymer and use thereof
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
US5607841A (en) * 1994-06-20 1997-03-04 Lipinski; Boguslaw Preparation and proteolytic degradation of a macromolecular protein complex from fibrinogen
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
SE9500778D0 (sv) 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
US5672685A (en) * 1995-10-04 1997-09-30 Duke University Source of apolipoprotein E and method of isolating apolipoprotein E
CA2274241C (en) * 1996-08-23 2003-05-27 Esperion Therapeutics Inc. A process for purifying apolipoprotein a or apolipoprotein e from human plasma
SE9603068D0 (sv) * 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
US6004925A (en) * 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
US5900376A (en) * 1997-11-07 1999-05-04 Geno Technology, Inc. Agent for protein precipitation, a method of protein precipitation, a method of protein assay using protein precipitation agent, and a kit for protein assay
US6875617B2 (en) * 1997-11-07 2005-04-05 Geno Technology, Inc. Agent for protein precipitation, a method of protein precipitation, a method of protein assay using protein precipitation agent, and a kit for protein assay
US7244828B2 (en) * 1997-11-07 2007-07-17 Aftab Alam Agent for protein precipitation, a method of protein precipitation, a method of protein assay using protein precipitation agent, and a kit for protein assay
DE19963420A1 (de) * 1999-12-28 2001-07-12 Sebo Gmbh Gewinnung von biologischen Komponenten aus Körperflüssigkeiten
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
DE10035352A1 (de) * 2000-07-20 2002-01-31 Zlb Bioplasma Ag Bern Verfahren zur Behandlung von instabiler Angina pectoris
WO2003000381A1 (en) * 2001-06-25 2003-01-03 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US20030127386A1 (en) * 2001-06-25 2003-07-10 Bomberger David C. Hollow fiber contactor systems for removal of lipids from fluids
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
CA2451633C (en) * 2001-06-25 2010-11-30 Lipid Sciences, Inc. Systems and methods using a solvent for the removal of lipids from fluids
US20040241744A1 (en) * 2001-07-12 2004-12-02 Hiroaki Kohno Method of quantifying denatured lipoprotein, reagents for quantifying denatured lipoprotein, method of detecting circulatory disease and reagents for detecting circulatory disease
CA2496831A1 (en) * 2002-08-26 2004-03-04 Lipid Sciences, Inc. Treating alzheimers using delipidated protein particles
JP2007527387A (ja) * 2003-07-03 2007-09-27 リピッド サイエンシーズ，インコーポレイテッド 脂質含量の低下したｈｄｌの粒子誘導体を製造するための方法及び装置
US7393826B2 (en) * 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
WO2005051413A2 (en) * 2003-11-26 2005-06-09 Novartis Ag Disease associated genes
JP4534511B2 (ja) * 2004-02-16 2010-09-01 東ソー株式会社 リポ蛋白を含んだ凍結乾燥試料
KR100719389B1 (ko) 2005-10-18 2007-05-17 주식회사 녹십자 인간혈장으로부터 아포리포단백질 ａ-ｉ을 분리 정제하는방법
US20080206142A1 (en) * 2006-06-16 2008-08-28 Lipid Sciences, Inc. Novel Peptides That Promote Lipid Efflux
WO2007149355A2 (en) * 2006-06-16 2007-12-27 Lipid Sciences, Inc. Novel peptides that promote lipid efflux
US20080227686A1 (en) * 2006-06-16 2008-09-18 Lipid Sciences, Inc. Novel Peptides that Promote Lipid Efflux
US20080138284A1 (en) * 2006-09-26 2008-06-12 Lipid Sciences, Inc. Novel Peptides That Promote Lipid Efflux
US7956035B2 (en) * 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
US8247235B2 (en) 2007-06-08 2012-08-21 Quest Diagnostics Investments Incorporated Lipoprotein analysis by differential charged-particle mobility
CA3054541C (en) * 2007-06-08 2022-11-29 Quest Diagnostics Investments Incorporated Lipoprotein analysis by differential charged-particle mobility
NZ582170A (en) 2007-08-17 2012-02-24 Csl Behring Gmbh Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i
US8324366B2 (en) 2008-04-29 2012-12-04 Alnylam Pharmaceuticals, Inc. Compositions and methods for delivering RNAI using lipoproteins
US9354200B1 (en) 2008-08-07 2016-05-31 Quest Diagnostics Investments Incorporated Detection apparatus for differential-charged particle mobility analyzer
WO2011008845A1 (en) 2009-07-14 2011-01-20 Toray Plastics (America), Inc. Crosslinked polyolefin foam sheet with exceptional softness, haptics, moldability, thermal stability and shear strength
EP3492085A1 (en) 2010-06-30 2019-06-05 CSL Limited A reconstituted high density lipoprotein formulation and production method therof
US9250211B2 (en) 2010-12-30 2016-02-02 Quest Diagnostics Investments Incorporated Magnetic separation of lipoproteins using dextran sulfate
US9125943B2 (en) 2012-11-02 2015-09-08 Csl Limited Reconstituted HDL formulation
JP6404333B2 (ja) 2013-06-05 2018-10-10 シーエスエル、リミテッド アポリポタンパク質ａ−ｉ（アポａ−ｉ）の製造方法
HK1225737B (en) 2013-08-08 2017-09-15 Csl Limited Ways to remove contaminants
JP7550448B2 (ja) 2017-11-22 2024-09-13 エイチディーエル セラピューティクス インコーポレイテッド 血漿処理システムの流体回路をプライミングするシステムおよび方法
AU2018396009A1 (en) 2017-12-28 2020-07-16 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
EP3917943A4 (en) * 2019-02-01 2022-12-07 Ohio State Innovation Foundation PROTEINS PURIFICATION PROCEDURES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
JPS596289B2 (ja) * 1977-12-20 1984-02-10 泰生 柴田 修飾人血漿タンパクの製法
AT380167B (de) * 1983-06-29 1986-04-25 Immuno Ag Verfahren zum trennen und gegebenenfalls bestimmen von lipoproteinfraktionen
JPS6153222A (ja) * 1984-08-21 1986-03-17 Otsuka Pharmaceut Factory Inc インスリン作用増強剤

Also Published As

Publication number Publication date
ES2042058T3 (es) 1996-07-16
JP2756132B2 (ja) 1998-05-25
EP0329605A1 (de) 1989-08-23
CA1335077C (en) 1995-04-04
JPH01294699A (ja) 1989-11-28
ATE72121T1 (de) 1992-02-15
US5089602A (en) 1992-02-18
DE58900776D1 (de) 1992-03-12
EP0329605B1 (de) 1992-01-29

Similar Documents

Publication Publication Date Title
ES2042058T3 (es) Procedimiento para preparar apoliproteinas a partir de fracciones de plasma sanguineo o suero.
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
AU6305990A (en) Process for refrigerating, corresponding refrigerating cycle and their application to the distillation of air
AU4992985A (en) Method and system for removing immunosuppressive components from the blood of mammals
NO892251L (no) Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker.
DE69010000D1 (de) Expression von menschlichen apolipoproteinen ai-milano in hefe.
AU2982889A (en) Novel dosage form of fenofibrate
FI881507L (fi) Erittäin puhtaat alditoli-diasetaalit, jotka eivät sisällä orgaanisia liuotinjäämiä, sekä menetelmät niiden valmistamiseksi
NO901665L (no) Fremgangsmaate ved utvinning av naturgass.
NO174105C (no) Analogifremgangsmåte for fremstilling av antikoagulerende peptider
HU913583D0 (en) Process for the production of substituted azoles and of medical preparations containing them
NO883392L (no) Fremgangsmaate ved fremstilling av tiometyl- og sulfinylmetylderivater.
AU4101589A (en) Pharmaceutical preparations which can be applied transdermally, containing sterolins and/or spiroketalins
AU2861389A (en) Disubstituted pyridines
GR3005036T3 (enExample)
NO883265D0 (no) Fremgangsmaate for rensing av olivenolje.
AU4511189A (en) Specific removal of ldl from blood
FR2611342B3 (fr) Appareillage pour le lavage et l'essorage par centrifugation de legumes, herbes potageres et similaires
NO890129D0 (no) Fremgangsmaate ved inaktivering av sykdomsfremkallende materialer i blodplasmaprodukter.
EP0112563A3 (en) Solvent treatment of plasma protein products
AU687451B2 (en) Process for producing a virus-inactivated factor VIII-containing fraction by chromatographic methods
EP0158317A3 (en) Biologic and method of preparing same
AU1092588A (en) Expression of the p. falciparum circumsporozoite protein by yeast
MY118087A (en) A method for the aptitude testing of protein fractions containing factor viii
ATE153379T1 (de) Expression von proteinsüssmitteln in hefe